{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:44:20Z","timestamp":1740116660381,"version":"3.37.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clineuro.2018.06.040","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T17:59:04Z","timestamp":1530554344000},"page":"130-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-7132","authenticated-orcid":false,"given":"Daniel","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Hieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"B\u00f6rtlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Buchthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"W\u00e4chter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clineuro.2018.06.040_bib0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1468-1331.2007.01922.x","article-title":"Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia","volume":"14","author":"Skogseid","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2018.06.040_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.71.2.193","article-title":"Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia","volume":"71","author":"Hilker","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.clineuro.2018.06.040_bib0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","article-title":"The impact of blepharospasm and cervical dystonia on health-related quality of life and depression","volume":"249","author":"Muller","year":"2002","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2018.06.040_bib0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0404.2008.01111.x","article-title":"Impact of dystonia on quality of life and health in a Swedish population","volume":"119","author":"Zetterberg","year":"2009","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.clineuro.2018.06.040_bib0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archopht.124.1.116","article-title":"Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm","volume":"124","author":"Hall","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"8","key":"10.1016\/j.clineuro.2018.06.040_bib0030","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.clineuro.2018.06.040_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov. Disord."},{"issue":"19","key":"10.1016\/j.clineuro.2018.06.040_bib0040","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development subcommittee of the American academy of neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.06.040_bib0045","doi-asserted-by":"crossref","unstructured":"H.H. Fernandez, J. Jankovic, J.B. Holds, D. Lin, J. Burns, A. Verma, K. Sethi, E.J. Pappert, Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm, Tremor and other hyperkinetic movements 4 (2014) 238.","DOI":"10.5334\/tohm.181"},{"issue":"1","key":"10.1016\/j.clineuro.2018.06.040_bib0050","article-title":"Botulinum toxin type A therapy for blepharospasm","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.clineuro.2018.06.040_bib0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","article-title":"What are the determinants of quality of life in people with cervical dystonia?","volume":"72","author":"Ben-Shlomo","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.clineuro.2018.06.040_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Mov. Disord."},{"issue":"Suppl. (14)","key":"10.1016\/j.clineuro.2018.06.040_bib0065","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1002\/mds.20957","article-title":"Deep brain stimulation: postoperative issues","volume":"21","author":"Deuschl","year":"2006","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.clineuro.2018.06.040_bib0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","article-title":"Neurostimulation for Parkinson\u2019s disease with early motor complications","volume":"368","author":"Schuepbach","year":"2013","journal-title":"New Engl. J. Med."},{"issue":"11","key":"10.1016\/j.clineuro.2018.06.040_bib0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/mds.26415","article-title":"New clinical trials for nonmotor manifestations of Parkinson\u2019s disease","volume":"30","author":"Schrag","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2018.06.040_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fneur.2017.00561","article-title":"Botulinumtoxin improves both generic and disease-specific quality of life in cervical dystonia","volume":"8","author":"Weiss","year":"2017","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2018.06.040_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756285616682676","article-title":"Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm","volume":"10","author":"Weiss","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"12","key":"10.1016\/j.clineuro.2018.06.040_bib0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(12)70257-0","article-title":"Pallidal deep brain stimulation in patients with primary generalised or segmental Dystonia: 5-year follow-up of a randomised trial","volume":"11","author":"Volkmann","year":"2012","journal-title":"Lancet Neurol."},{"issue":"19","key":"10.1016\/j.clineuro.2018.06.040_bib0095","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMoa063618","article-title":"Pallidal deep-brain stimulation in primary generalized or segmental dystonia","volume":"355","author":"Kupsch","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2018.06.040_bib0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol","year":"1990","journal-title":"Health Policy"},{"issue":"57","key":"10.1016\/j.clineuro.2018.06.040_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol"},{"issue":"4","key":"10.1016\/j.clineuro.2018.06.040_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01676830490506041","article-title":"Impact on quality of life of botulinum toxin treatments for essential blepharospasm","volume":"23","author":"MacAndie","year":"2004","journal-title":"Orbit"},{"issue":"9","key":"10.1016\/j.clineuro.2018.06.040_bib0115","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11136-011-9890-y","article-title":"Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin","volume":"20","author":"Setthawatcharawanich","year":"2011","journal-title":"Qual. Life Res."},{"issue":"9","key":"10.1016\/j.clineuro.2018.06.040_bib0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00702-013-0998-9","article-title":"Sustained efficacy and safety of repeated incobotulinumtoxinA (xeomin((R))) injections in blepharospasm","volume":"120","author":"Truong","year":"2013","journal-title":"J. Neural Transm. (Vienna)"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718302610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718302610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T22:05:49Z","timestamp":1720389949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846718302610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"alternative-id":["S0303846718302610"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.06.040","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}